OUTSOURCED PHARMA CAPACITY UPDATE SMALL MOLECULE VIDEOS
Douglas CDMO Capacity Update July 2024: Small Molecule Finished Dosage Form
We specialize in high-potency softgels and liquids and have deep experience producing prescription drugs for classifications including oncology, dermatology, the central nervous system and immunity.
Alcami Capacity Update July 2024: Small Molecule Finished Dosage Form
Alcami boasts a state-of-the-art OSD development suite that includes manufacturing equipment, non-GMP analytical testing lab, stability chambers, and small scale blistering equipment.
AustinPx Capacity Update July 2024: Small Molecule Finished Dosage Form
Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges.
Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development
Learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.
AbbVie Capacity Update July 2024: Small Molecule APl And HPAPI Development
Review a detailed examination of our HPAPI & API capabilities, with a particular focus on our Campoverdi, Italy facility which currently has capacity available for near-term projects.
Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development
Learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.
Adare Pharma Solutions Capacity Update May 2024: Small Molecule APl and HPAPI Development
An outsourcing partner with services from the earliest phases of development and formulation to manufacturing and packaging is critical for advancing your product to market with reduced cost and time.
Lonza Capacity Update May 2024: Small Molecule APl and HPAPI Development
With 37 cGMP mills of different sizes and types, and dedicated areas for steroids, HPAPIs, and even cryogenic milling, our Monteggio site is well-equipped to support a wide range of customer projects.
MilliporeSigma Capacity Update May 2024: Small Molecule APl and HPAPI Development
Our small molecule API CDMO team has the expertise, experience, and specialized facilities to make our customers' small molecule API projects a success.
Ajinomoto Bio-Pharma Services Capacity Update May 2024: Small Molecule APl and HPAPI Development
Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late stage projects.
Ajinomoto Bio-Pharma Services Capacity Update February 2024: Small Molecule
Explore the recent expansions of Ajinomoto BPS. Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late-stage projects.
Cambrex Capacity Update February 2024: Small Molecule
Cambrex offers strong expertise in custom development and cGMP API manufacturing for small molecules, including HPAPI, through its Charles City, Iowa facility.
Nanoform Capacity Update February 2024: Small Molecule
Discover Nanoform’s manufacturing capabilities, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients.
Societal CDMO Capacity Update February 2024: Small Molecule
Societal provides development, regulatory support, clinical and commercial manufacturing, packaging, and logistics services. Delve into Societal’s capabilities and open capacity across sites.
Don't miss our next installment!
These conferences are ideal for professionals who have the authority to choose and manage CDMO relationships and need to secure capacity for their development or commercial programs.
How can we help?
Are you a supplier looking to present at our next event?